Global Vacuum-Assisted Breast Biopsy Device Market

Vacuum-Assisted Breast Biopsy Device Market Size, Share, Growth Analysis, By Procedure(Tethered, Untethered), By Product(Vacuum-Assisted Biopsy Systems, Vacuum-Assisted Biopsy Needles), By Type(9-12G, <9G), By Technique(Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy), By End User(Hospitals, Academic) - Industry Forecast 2024-2031


Report ID: SQSG35A2046 | Region: Global | Published Date: April, 2024
Pages: 286 | Tables: 146 | Figures: 78

Vacuum-Assisted Breast Biopsy Device Market Insights

Global Vacuum-Assisted Breast Biopsy Device Market size was valued at USD 726.81 million in 2019 and is poised to grow from USD 811.85 million in 2023 to USD 2197.62 million by 2031, growing at a CAGR of 11.7% in the forecast period (2024-2031).

The response time of vacuum-assisted breast biopsy (VABB) is faster than that of other diagnostic devices. The rising prevalence of breast cancer is driving the growth of the vacuum-assisted breast biopsy market. Because of their ability to obtain large amounts of tissues with contiguous specimens, the ability to obtain multiple specimens with single needle insertion, a more accurate diagnosis with a lower cancer miss rate, and lower histological underestimates, vacuum-assisted breast biopsy (VABB) devices are gaining popularity over traditional biopsy methods.

Breast cancer is one of the most common diseases afflicting women in both developed and developing countries. Breast cancer is the second-leading cause of cancer-related deaths in women worldwide, according to the American Cancer Society. The rising number of breast cancer cases has compelled governments around the world to raise awareness about the importance of early detection, which is expected to drive vacuum-assisted breast biopsy device market growth.

US Vacuum-Assisted Breast Biopsy Device Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 726.81 million

Largest Segment

Hospitals

Fastest Growth

Academic and Research Institutes

Growth Rate

11.7% CAGR

Global Vacuum-Assisted Breast Biopsy Device Market, 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
Global Vacuum-Assisted Breast Biopsy Device Market Size By End User, 2021-2028 ($ Bn)
Global Vacuum-Assisted Breast Biopsy Device Market Size By End User, 2021-2028 (%)

To get more reports on the above market click here to Buy The Report

Vacuum-Assisted Breast Biopsy Device Market Segmental Analysis

The Global Vacuum-Assisted Breast Biopsy Device Market is segmented based on the Procedure, Product, Type, Technique, End user, and region. Based on the Procedure, the market is bifurcated into Tethered, and Untethered. Based on the Product, the market is bifurcated into Vacuum-Assisted Biopsy Systems, and Vacuum-Assisted Biopsy Needles. Based on the Type, the market is segmented into 9-12G, <9G, and >12G. Based on the Technique, the market is segmented into Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, and Others. Based on the End User, the market is segmented into Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, and Others. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Vacuum-Assisted Breast Biopsy Device Market Analysis by Product

Based on Product, the vacuum-assisted breast biopsy device market is bifurcated into Vacuum-Assisted Biopsy Systems, and Vacuum-Assisted Biopsy Needles. The market is dominated by Vacuum-Assisted Biopsy needles, The segment was valued at USD 142.47 million in 2021, which is projected to reach USD 197.66 million by 2028 at a CAGR of 4.2%. The rising prevalence of cancer, government and global health organization initiatives, and an increasing preference for minimally invasive procedures are the major factors driving the growth of the vacuum-assisted biopsy needles market. Breast lesions are detected using a variety of image-guiding techniques such as ultrasound, MRI, mammograms, X-rays, and so on. The sample extraction procedure is carried out concurrently. It allows the area of abnormality to be precisely located using imaging guidance so that only samples from the region of interest are removed. As a result, the vacuum-assisted breast biopsy device's reliance on monitoring devices raises the demand for Vacuum-Assisted Biopsy Systems.

Vacuum-Assisted Breast Biopsy Device Market Analysis by End User

Based on the End User, the market is segmented into Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, and Others. In 2021, the hospital segment dominated the global vacuum-assisted breast biopsy device market, and it is anticipated to maintain its dominance throughout the forecast period. The segment was valued at USD 154.84 million in 2021 which is projected to reach USD 207.91 million by 2028 at a CAGR of 4.3%. The increasing number of patients visiting hospitals, rising number of in-house diagnostic procedures performed in hospitals, and growing awareness regarding early diagnosis are the major driving the growth of this segment. Furthermore, diagnostic and imaging centers are expected to be the fastest growing segment due to rising healthcare infrastructure and healthcare spending, which is anticipated to drive the demand for advanced cancer diagnostic devices such as vacuum-assisted breast biopsy devices.

Global Vacuum-Assisted Breast Biopsy Device Market By End User , 2021(%), 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Vacuum-Assisted Breast Biopsy Device Market Regional Insights

The North America region dominates the global vacuum-assisted breast biopsy device market and is projected to maintain a similar trend over the forecast period. North America's vacuum-assisted breast biopsy device market is projected to grow at a CAGR of 4.4% over the forecast period. The US is also the fastest growing country in the region followed by Canada. Each year, over 1 million breast biopsies are performed in the United States, The American Cancer Society, advises women to participate in self-awareness exams held throughout the year, which help individuals detect any changes in their breast that would be further diagnosed by a physician. Moreover, among all the region, The Asia pacific region is fastest growing market. There has been an exponential rise in breast cancer cases in Asian countries over the last few decades. According to a study on breast cancer in Asia, breast cancer mortality increased among Asian women due to a higher prevalence of breast cancer risk factors such as delayed childbirth, and increased obesity.

Global Vacuum-Assisted Breast Biopsy Device Market By Geography, 2021 - 2028, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Vacuum-Assisted Breast Biopsy Device Market Dynamics

Vacuum-Assisted Breast Biopsy Device Market Driver

High accuracy of Vacuum-assisted breast biopsy (VABB) devices is anticipated to drive the market growth

  • Vacuum-assisted breast biopsy (VABB) devices are gaining immense popularity over conventional biopsy methods because of their ability to obtain large number of tissues with contiguous specimens, the possibility of acquiring multiple specimens with single insertion of a needle, a more accurate diagnosis with a lower cancer miss rate and lower histological underestimates. Apart from the diagnostic indications, VABB is also a recognized method of therapeutic removal of benign lesions such as fibroadenomas. The use of percutaneous VABB can reduce the need for open surgical biopsy or excision, and minimize costs of the operating theatre or hospital stays associated with surgical excision. Hence, all of these factors are driving the growth of Vacuum-assisted breast biopsy (VABB) devices.

Vacuum-Assisted Breast Biopsy Device Market Restraint

High cost of VABB devices

The use of VABB is associated with a higher capital cost such as vacuum generators and biopsy hand-pieces as well as a higher running cost of the consumables, including needles, tubing and localizing markers. Due to its higher cost when compared to Fine needle aspiration (FNA) biopsy or core biopsy, VABB is often used as a second line of biopsy in some hospitals and research centers. In such circumstances, VABB is only conducted after inadequate or inconclusive cytology or histology, or when previous FNA or core biopsies yielded contradictory imaging-pathology results.

Request Free Customization of this report to help us to meet your business objectives.

Vacuum-Assisted Breast Biopsy Device Market Competitive Landscape

The market is dominated by Becton Dickinson and Co (Bd), Devicor Medical Products Inc (Mammotome) and Hologic Inc. Key players in the vacuum-assisted breast biopsy device market are adopting strategies like product launch, merger, and acquisition, and high R&D investments to gain a significant market share. For instance, In March 2021, IZI Medical Products, LLC launched The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy. Quick-Core Auto is a lightweight, fully automatic biopsy system that offers the precision, dependability, and quality of IZI's Quick-Core semi-automatic biopsy system.

Vacuum-Assisted Breast Biopsy Device Market Top Player's Company Profiles

  • Hologic, Inc.
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • Devicor Medical Products, Inc.
  • Becton, Dickinson and Company
  • Argon Medical Devices, Inc.
  • INRAD, Inc.
  • Medtronic plc
  • STERYLAB S.r.l.
  • Scion Medical Technologies LLC
  • Galini SRL
  • Biopsybell Srl
  • SOMATEX Medical Technologies GmbH
  • Tsunami Medical Srl
  • Micro-Tech (Nanjing) Co., Ltd.
  • Hangzhou AGS MedTech Co., Ltd.
  • Pantheon Medical Technologies S.r.l.
  • Andiamo Corporation
  • OncoCyte Corporation
  • Biodesix, Inc.

Vacuum-Assisted Breast Biopsy Device Market Recent Developments

  • In June 2022, Medtronic Plc received FDA 510(k) clearance and CE Mark approval for the integration of advanced INVOS regional oximetry and Micro stream capnography technologies on the CARESCAPE precision monitoring platform. Micro stream capnography (CO2) technology captures evolving respiratory compromise, while INVOSTM regional oximetry (rSO2) technology helps clinicians predict and prevent perioperative complications faster than traditional peripheral measurement.
  • In March 2021, IZI Medical Products, LLC launched The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy. Quick-Core Auto is a lightweight, fully automatic biopsy system that offers the precision, dependability, and quality of IZI's Quick-Core semi-automatic biopsy system.

Vacuum-Assisted Breast Biopsy Device Key Market Trends

Rising government support and growing public awareness regarding early detection of breast cancer

  • The vacuum-assisted breast biopsy device market is growing as a result of a broad and vigorous research environment, which has contributed to the development of more accurate and minimally invasive treatments for the early detection of breast cancer. Governments have also attempted to create a stable and all-encompassing environment for cancer research, which has aided in the development of these diagnostic devices.
  • Moreover, attractive reimbursements have considerably strengthened the health of this sector. Breast cancer awareness campaigns are raising public awareness about the importance of early identification of breast cancer, which is fueling the growth of the market.

Vacuum-Assisted Breast Biopsy Device Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our Global vacuum-assisted breast biopsy device market analysis, we discovered that despite the high cost of vacuum-assisted breast biopsy devices, key players are focusing on entering developed countries. For developing and underdeveloped countries, there are few or no direct distributors. For Increasing market share, Companies have to build a supply chain in developing countries. Based on Product, the market is dominated by vacuum-assisted biopsy needles. Moreover, Based on End user, the market is dominated by the Hospitals segment. Due to their ability to obtain large amounts of tissues with contiguous specimens, the ability to obtain multiple specimens with a single needle insertion, the ability to diagnose cancer more accurately with a lower cancer miss rate, and a lower rate of histological underestimates, vacuum-assisted breast biopsy (VABB) devices are becoming more and more popular over traditional biopsy methods.

Report Metric Details
Market size value in 2023 USD 726.81 million
Market size value in 2031 USD 2197.62 million
Growth Rate 11.7%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Procedure
    • Tethered, Untethered
  • Product
    • Vacuum-Assisted Biopsy Systems, Vacuum-Assisted Biopsy Needles
  • Type
    • 9-12G, <9G, <12G
  • Technique
    • Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others
  • End User
    • Hospitals, Academic, Research Institutes, Diagnostic, Imaging Centers, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Hologic, Inc.
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • Devicor Medical Products, Inc.
  • Becton, Dickinson and Company
  • Argon Medical Devices, Inc.
  • INRAD, Inc.
  • Medtronic plc
  • STERYLAB S.r.l.
  • Scion Medical Technologies LLC
  • Galini SRL
  • Biopsybell Srl
  • SOMATEX Medical Technologies GmbH
  • Tsunami Medical Srl
  • Micro-Tech (Nanjing) Co., Ltd.
  • Hangzhou AGS MedTech Co., Ltd.
  • Pantheon Medical Technologies S.r.l.
  • Andiamo Corporation
  • OncoCyte Corporation
  • Biodesix, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Vacuum-Assisted Breast Biopsy Device Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Vacuum-Assisted Breast Biopsy Device Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Vacuum-Assisted Breast Biopsy Device Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Vacuum-Assisted Breast Biopsy Device Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Vacuum-Assisted Breast Biopsy Device Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Vacuum-Assisted Breast Biopsy Device Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Vacuum-Assisted Breast Biopsy Device Market size was valued at USD 726.81 million in 2019 and is poised to grow from USD 811.85 million in 2023 to USD 2197.62 million by 2031, growing at a CAGR of 11.7% in the forecast period (2024-2031).

The market is dominated by Becton Dickinson and Co (Bd), Devicor Medical Products Inc (Mammotome) and Hologic Inc. Key players in the vacuum-assisted breast biopsy device market are adopting strategies like product launch, merger, and acquisition, and high R&D investments to gain a significant market share. For instance, In March 2021, IZI Medical Products, LLC launched The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy. Quick-Core Auto is a lightweight, fully automatic biopsy system that offers the precision, dependability, and quality of IZI's Quick-Core semi-automatic biopsy system. 'Hologic, Inc.', 'C. R. Bard, Inc.', 'Cook Medical LLC', 'Devicor Medical Products, Inc.', 'Becton, Dickinson and Company', 'Argon Medical Devices, Inc.', 'INRAD, Inc.', 'Medtronic plc', 'STERYLAB S.r.l.', 'Scion Medical Technologies LLC', 'Galini SRL', 'Biopsybell Srl', 'SOMATEX Medical Technologies GmbH', 'Tsunami Medical Srl', 'Micro-Tech (Nanjing) Co., Ltd.', 'Hangzhou AGS MedTech Co., Ltd.', 'Pantheon Medical Technologies S.r.l.', 'Andiamo Corporation', 'OncoCyte Corporation', 'Biodesix, Inc.'

Vacuum-assisted breast biopsy (VABB) devices are gaining immense popularity over conventional biopsy methods because of their ability to obtain large number of tissues with contiguous specimens, the possibility of acquiring multiple specimens with single insertion of a needle, a more accurate diagnosis with a lower cancer miss rate and lower histological underestimates. Apart from the diagnostic indications, VABB is also a recognized method of therapeutic removal of benign lesions such as fibroadenomas. The use of percutaneous VABB can reduce the need for open surgical biopsy or excision, and minimize costs of the operating theatre or hospital stays associated with surgical excision. Hence, all of these factors are driving the growth of Vacuum-assisted breast biopsy (VABB) devices.

The vacuum-assisted breast biopsy device market is growing as a result of a broad and vigorous research environment, which has contributed to the development of more accurate and minimally invasive treatments for the early detection of breast cancer. Governments have also attempted to create a stable and all-encompassing environment for cancer research, which has aided in the development of these diagnostic devices.

The North America region dominates the vacuum-assisted breast biopsy device market and is projected to maintain a similar trend over the forecast period. North America's vacuum-assisted breast biopsy device market is projected to grow at a CAGR of 4.4% over the forecast period. The US is also the fastest growing country in the region followed by Canada. Each year, over 1 million breast biopsies are performed in the United States, The American Cancer Society, advises women to participate in self-awareness exams held throughout the year, which help individuals detect any changes in their breast that would be further diagnosed by a physician. Moreover, among all the region, The Asia pacific region is fastest growing market. There has been an exponential rise in breast cancer cases in Asian countries over the last few decades. According to a study on breast cancer in Asia, breast cancer mortality increased among Asian women due to a higher prevalence of breast cancer risk factors such as delayed childbirth, and increased obesity.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Vacuum-Assisted Breast Biopsy Device Market

Product ID: SQSG35A2046

$5,300
BUY NOW GET FREE SAMPLE